Inducible clindamycin resistance among methicillin- sensitive staphylococcus aureus infections in pediatric patients

Israel Medical Association Journal

Volumn 13, Issue 10, 2011, Pages 605-608

  Shouval, Dror S ^a,c   Samra, Zmira ^b,c   Shalit, Itamar ^a,c   Livni, Gilat ^a,c   Bilvasky, Efraim ^a,c   Ofir, Orit ^b,c   Gadba, Rachamim ^b,c   Amir, Jacob ^a,c  

^a SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

^b RABIN MEDICAL CENTER   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

Antibiotic; Clindamycin resistance; Methicillinsensitive; Pediatrics; Staphylococcus aureus

Indexed keywords

CHLORAMPHENICOL; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; FUSIDIC ACID; GENTAMICIN; MINOCYCLINE; OFLOXACIN; PENICILLIN G; RIFAMPICIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL STRAIN; BACTERIOPHAGE TYPING; BACTERIUM CULTURE; BACTERIUM ISOLATE; CHILD; CONTROLLED STUDY; HUMAN; INDUCIBLE CLINDAMYCIN RESISTANCE; ISRAEL; MEDICAL RECORD REVIEW; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; NONHUMAN; PRESCHOOL CHILD; RANDOM AMPLIFIED POLYMORPHIC DNA; REVIEW;

BACTERIOPHAGE TYPING; CHILD, PRESCHOOL; CLINDAMYCIN; DRUG RESISTANCE, BACTERIAL; HUMANS; METHICILLIN; MICROBIAL SENSITIVITY TESTS; NUCLEIC ACID AMPLIFICATION TECHNIQUES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 80054100039     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (25)

1. Steward CD, Raney PM, Morrell AK, et al. Testing for induction of clindamycin resistance in erythromycin-resistant isolates of Staphylococcus aureus. J Clin Microbiol 200; 43: 1716-21.
2. Patel M, Waites KB, Moser SA, Cloud GA, Hoesley CJ. Prevalence of inducible clindamycin resistance among community- and hospital-associated Staphylococcus aureus isolates. J Clin Microbiol 2006; 44: 2481-4.
3. Braun L, Craft D, Williams R, Tuamokumo F, Ottolini M. Increasing clindamycin resistance among methicillin-resistant Staphylococcus aureus in 57 northeast United States military treatment facilities. Pediatr Infect Dis J 2005; 24: 622-6.
4. Chavez-Bueno S, Bozdogan B, Bowlware KL, et al. Inducible clindamycinresistance and molecular epidemiologic trends of pediatric communityacquired methicillin-resistant Staphylococcus aureus in Dallas, Texas. Antimicrob Agents Chemother 2005; 49: 2283-8.
5. Kaplan SL, Hulten KG, Gonzalez BE, et al. Three-year surveillance of community-acquired Staphylococcus aureus infections in children. Clin Infect Dis 2005; 40: 1785-91.
6. Regev-Yochay G, Carmeli Y, Raz M, et al. Prevalence and genetic relatedness of community-acquired methicillin-resistant Staphylococcus aureus in Israel. Eur J Clin Microbiol Infect Dis 2006; 25: 719-22.
7. Schlesinger Y, Yahalom S, Raveh D, et al. Methicillin-resistant Staphylococcus aureus nasal colonization in children in Jerusalem: community vs. chronic care institutions. IMAJ Isr Med Assoc J 2003; 5: 847-51.
8. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Approval standard M100-S17. Wayne, PA, 2007.
9. Blair JE, Williams REQ. Phage typing of staphylococci. Bull WHO 1961; 24: 771-84.
10. Tambic A, Power EG, Talsania H, Anthony RM, French GL. Analysis of an outbreak of non-phage-typeable methicillin-resistant Staphylococcus aureus by using a randomly amplified polymorphic DNA assay. J Clin Microbiol 1997; 35: 3092-7.
11. Gorak EJ, Yamada SM, Brown JD. Community-acquired methicillin-resistant Staphylococcus aureus in hospitalized adults and children without known risk factors. Clin Infect Dis 1999; 29: 797-800.
12. Daum RS. Clinical practice. Skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus. N Engl J Med 2007; 357: 380-90.
13. Nevet A, Ashkenazi S, Samra Z, Livni G. Community-associated methicillinresistant Staphylococcus aureus infections in Israel. IMAJ Isr Med Assoc J 2010; 12: 428-30.
14. Siberry GK, Tekle T, Carroll K, Dick J. Failure of clindamycin treatment of methicillin-resistant Staphylococcus aureus expressing inducible clindamycin resistance in vitro. Clin Infect Dis 2003; 37: 1257-60.
15. Schreckenberger PC, Ilendo E, Ristow KL. Incidence of constitutive and inducible clindamycin resistance in Staphylococcus aureus and coagulasenegative staphylococci in a community and a tertiary care hospital. J Clin Microbiol 2004; 42: 2777-9.
16. Fokas S, Fokas S, Tsironi M, Kalkani M, Dionysopouloy M. Prevalence of inducible clindamycin resistance in macrolide-resistant Staphylococcus spp. Clin Microbiol Infect 2005; 11: 337-40.
17. Frank AL, Marcinak JF, Mangat PD, et al. Clindamycin treatment of methicillinresistant Staphylococcus aureus infections in children. Pediatr Infect Dis J 2002; 21: 530-4.
18. Lina G, Quaglia A, Reverdy ME, Leclercq R, Vandenesch F, Etienne J. Distribution of genes encoding resistance to macrolides, lincosamides, and streptogramins among staphylococci. Antimicrob Agents Chemother 1999; 43: 1062-6.
19. Kim HB, Lee B, Jang HC, et al. A high frequency of macrolide-lincosamidestreptogramin resistance determinants in Staphylococcus aureus isolated in South Korea. Microb Drug Resist 2004; 10: 248-54.
20. Saribas Z, Tunckanat F, Pinar A. Prevalence of erm genes encoding macrolidelincosamide- streptogramin (MLS) resistance among clinical isolates of Staphylococcus aureus in a Turkish university hospital. Clin Microbiol Infect 2006; 12: 797-9.
21. Janapatla RP, Yan JJ, Huang AH, Chen HM, Wu HM, Wu JJ. Inducible clindamycin resistance in Staphylococcus aureus isolates causing bacteremia at a university hospital in southern Taiwan. Diagn Microbiol Infect Dis 2007; 58: 203-9.
22. Daurel C, Huet C, Dhalluin A, Bes M, Etienne J, Leclercq R. Differences in potential for selection of clindamycin-resistant mutants between inducible erm(A) and erm(C) Staphylococcus aureus genes. J Clin Microbiol 2008; 46: 546-50.
23. Murphy E. Nucleotide sequence of ermA, a macrolide-lincosamide-streptogramin B determinant in Staphylococcus aureus. J Bacteriol 1985; 162: 633-40.
24. Lewis JS 2nd, Jorgensen JH. Inducible clindamycin resistance in Staphylococci: should clinicians and microbiologists be concerned? Clin Infect Dis 2005; 40: 280-5.
25. Korownyk C, Allan GM. Evidence-based approach to abscess management. Can Fam Physician 2007; 53: 1680-4.